Treatment of sialorrhea in patients under long-term ventilation;Behandlung der sialorrhoe bei beatmeten patienten

Pneumologie

Volumn 62, Issue SUPPL. 1, 2008, Pages

  Winterholler, M ^a  

^a Krankenhaus Rummelsberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BOTULINUM TOXIN; SCOPOLAMINE;

ASSISTED VENTILATION; HUMAN; HYPERSALIVATION; NEUROMUSCULAR DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SALIVA; SALIVARY GLAND;

BOTULINUM TOXIN TYPE A; HUMANS; LONG-TERM CARE; NEUROMUSCULAR DISEASES; PHYSICAL THERAPY MODALITIES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RESPIRATION DISORDERS; RESPIRATION, ARTIFICIAL; SIALORRHEA;

EID: 42149094518     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016440     Document Type: Review

References (23)

1. Borg M, Hirst F. The role of radiation therapy in the management of sialorrhea. Int J Radiât Oncol Biol Phys 1998; 41: 1113-1119
2. Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988; 3: 73-78
3. Lopez-Jornet P, Bermejo-Fenoll A. Disorders of secretion: hiposecretion and sialorrhea. Med Oral 1996; 1: 96-106
4. Tscheng DZ. Sialorrhea - therapeutic drug options. Ann Pharmacother 2002; 36: 1785-1790
5. Nederfors T, Ericsson T, Twetman S et al. Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human parotid and submandibular-sublingual salivary secretion. J Dent Res 1994; 73: 5-10
6. Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 1996; 150: 932-935
7. Heine RG, Catto-Smith AG, Reddihough DS. Effect of antireflux medication on salivary drooling in children with cerebral palsy. Dev Med Child Neurol 1996; 38: 1030-1036
8. Fischer-Brandies H, Avalle C, Limbrock GJ. Therapy of orofacial dysfunctions in cerebral palsy according to Castillo-Morales: first results of a new treatment concept. Eur J Orthod 1987; 9: 139-143
9. Wong V, Sun JG, Wong W. Traditional Chinese medicine (tongue acupuncture) in children with drooling problems. Pediatr Neurol 2001; 25: 47-54
10. De Simone GG, Eisencblas JH, Junin M et al. Atropine drops for drooling: a randomized controlled trial. Palliat Med 2006; 20: 665-671
11. Lewis DW, Fontana C, Mehallick LK et al. Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol 1994; 36: 484-486
12. Talmi YP, Finkelstein Y, Zohar Y. Reduction of salivary flow with transdermal scopolamine: a four-year experience. Otolaryngol Head Neck Surg 1990; 103: 615-618
13. Mier RJ, Bachrach SJ, Lakin RC et al. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000; 154: 1214-1218
14. Bushara KO. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment-botulinum toxin A injections of the parotid glands. Med Hypotheses 1997; 48: 337-339
15. Winterholler M, Erbguth F. BoNT/A for the treatment of sialorrhea in ALS: serious side effects of a transductal approach. JNNP 2001; 70: 417
16. Berweck S, Feldkamp A, Francke A et al. Sonography-guided injection of botulinum toxin A in children with cerebral palsy. Neuropediatrics 2002; 33: 221-223
17. Ellies M, Rohrbach-Volland S, Arglebe C et al. Successful management of drooling with botulinum toxin A in neurologically disabled children. Neuropediatrics. 2002; 33: 327-330
18. Jongerius PH, Rotteveel JJ, Hoogen F van den et al. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr 2001; 160: 509-512
19. Jongerius PH, Hoogen FJ van den, Van Limbeek J et al. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 2004; 114: 620-627
20. Naumann M, Jost W. Botulinum toxin treatment of secretory disorders. Mov Disord 2004 Mar ; 19 Suppl 8: S137-141
21. Porta M, Gamba M, Bertacchi G et al. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001; 70: 538-540
22. Mankarious LA, Bottrill IA, Huchzermyer PM et al. Long-term follow-up of submandibular duct rerouting for the treatment of sialorrhea in the pediatric population. Otolaryngol Head Neck Surg 1999; 120: 303-307
23. Panarese A, Ghosh S, Hodgson D et al. Outcomes of submandibular duct re-implantation for sialorrhoea. Clin Otolaryngol 2001; 26: 143-146